Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-30 @ 11:29 PM
Study NCT ID:
NCT00002369
Status:
COMPLETED
Last Update Posted:
2007-10-02
First Post:
1999-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Drug Therapy, Combination | View |
| None | Zidovudine | View |
| None | Stavudine | View |
| None | HIV Protease Inhibitors | View |
| None | CD4 Lymphocyte Count | View |
| None | Lamivudine | View |
| None | Indinavir | View |
| None | Reverse Transcriptase Inhibitors | View |
| None | Anti-HIV Agents | View |
| None | Viral Load | View |